Stock Taper Total Revenue: $392.9 million, up 11% year-over-year.
Subscription Revenue: $276.7 million, up 14% year-over-year.
Monthly Average Revenue per Pet: $87.44, up 9% from the prior year.
Subscription Pets: Increased 5% year-over-year to 1,125,000 pets.
Adjusted Operating Income: $43.3 million, a 24% increase from Q2 2025, with a subscription adjusted operating margin of 15%.
Net Income: $6.8 million ($0.16 per share), down from $9.4 million ($0.22 per share) in the prior year due to a one-time gain last year.
Free Cash Flow: $19.2 million, up from $12 million year-over-year.
Cash and Short-term Investments: $398.5 million with total debt at $106.9 million.
Pet Acquisition: Added approximately 18,800 net subscription pets, a 39% increase year-over-year, driven by improved pet acquisition strategies and enhanced member experience.
Product Enhancements: Expanded deductible and coinsurance options to improve affordability and accessibility, with positive early results.
Technology Investments: Focus on AI and automation to enhance operational efficiency and member experience.
Share Repurchase Program: Announced a $100 million share repurchase program to enhance shareholder value.
Dividend: Received approval to dividend $44 million from its insurance entity, contributing to a total of $130 million unlocked over three years.
Full Year 2026 Revenue Guidance: Expected to be between $1.584 billion and $1.601 billion, with subscription revenue projected between $1.124 billion and $1.133 billion.
Adjusted Operating Income Guidance: Expected to be between $176 million and $184 million for the full year.
Q3 2026 Revenue Guidance: Anticipated to be between $399 million and $405 million, with subscription revenue between $284 million and $287 million.
Veterinary Inflation: Continues to be higher than historical levels, impacting pricing strategies and overall market dynamics.
Declining Visits to Veterinarians: Industry-wide downturn in new visits could affect future growth, despite a large addressable market of uninsured pets.
Cost of Pet Acquisition: Increased to $299 per pet, up from $276, indicating rising costs in acquiring new subscriptions.
Veterinary Inflation: Management noted ongoing double-digit veterinary inflation, which is influencing pricing strategies.
Share Repurchase Program: Clarified that the decision to repurchase shares will depend on maximizing returns compared to other investment opportunities.
Enrollment Services: Improvements in enrollment processes are expected to continue rolling out throughout the year, contributing to net new pet growth.
New Product Development: Updates on new insurance products and food initiatives indicate a long-term strategy to expand offerings, with significant progress expected by mid-2027. Overall, Trupanion reported strong financial performance in Q2 2026, with significant growth in adjusted operating income and net pet additions. The company remains focused on strategic investments and product enhancements while navigating challenges in the veterinary landscape.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT